99 related articles for article (PubMed ID: 3077575)
1. Anti-EGF receptor monoclonal antibodies: biological studies and potential clinical applications.
Mendelsohn J
Trans Am Clin Climatol Assoc; 1989; 100():31-8. PubMed ID: 3077575
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
J Natl Cancer Inst Monogr; 1992; (13):125-31. PubMed ID: 1389685
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
4. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
6. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.
Divgi CR; Welt S; Kris M; Real FX; Yeh SD; Gralla R; Merchant B; Schweighart S; Unger M; Larson SM
J Natl Cancer Inst; 1991 Jan; 83(2):97-104. PubMed ID: 1988695
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
8. The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
Semin Cancer Biol; 1990 Oct; 1(5):339-44. PubMed ID: 2103507
[TBL] [Abstract][Full Text] [Related]
9. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
[TBL] [Abstract][Full Text] [Related]
10. Binding of EGF peptide and EGF receptor antibodies and its fragments in different tumor models.
Senekowitsch-Schmidtke R
Hybridoma; 1999 Feb; 18(1):29-35. PubMed ID: 10211785
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study.
Crombet T; Torres O; Rodríguez V; Menéndez A; Stevenson A; Ramos M; Torres F; Figueredo R; Veitía I; Iznaga N; Pérez R; Lage A
Hybridoma; 2001 Apr; 20(2):131-6. PubMed ID: 11394532
[TBL] [Abstract][Full Text] [Related]
13. Effects of monoclonal antibody anti-EGF receptor on human nasopharyngeal carcinoma cell and other tumor cells.
Guan EN; Zhou TC; Wang JH; Chen Y; Sun YX; Huang PG; Tang WP; Zhao ML
Sci China B; 1990 Nov; 33(11):1334-40. PubMed ID: 2095159
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of human nasopharyngeal carcinoma in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Guan E; Zhou TC; Wang JH; Huang PG; Tang WP; Zhao ML; Chen Y; Sun YX
Int J Cell Cloning; 1989 Jul; 7(4):242-56. PubMed ID: 2768842
[TBL] [Abstract][Full Text] [Related]
15. Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking an autocrine pathway.
Mendelsohn J; Masui H; Goldenberg A
Trans Assoc Am Physicians; 1987; 100():173-8. PubMed ID: 3502661
[TBL] [Abstract][Full Text] [Related]
16. Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice.
Parker C; Roseman BJ; Bucana CD; Tsan R; Radinsky R
J Histochem Cytochem; 1998 May; 46(5):595-602. PubMed ID: 9562568
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225.
Ye D; Mendelsohn J; Fan Z
Oncogene; 1999 Jan; 18(3):731-8. PubMed ID: 9989823
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
Wu X; Fan Z; Masui H; Rosen N; Mendelsohn J
J Clin Invest; 1995 Apr; 95(4):1897-905. PubMed ID: 7706497
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
Fan Z; Baselga J; Masui H; Mendelsohn J
Cancer Res; 1993 Oct; 53(19):4637-42. PubMed ID: 8402640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
